RxDoctor Payments Data

Sasidhar Gunturu, MD

Psychosomatic Medicine · Bronx, NYNPI 1730443870

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 29.8% of the total. 2025 is the largest year on record at $1,903, 5.2 times the $369 reported in 2019. Among psychosomatic medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,889in general payments, 2019–2025

Across 44 payments — averaging $65.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$862
  • Johnson & Johnson$791
  • Neurocrine Biosciences, Inc.$546
  • AbbVie$381
  • Teva Pharmaceuticals USA, Inc.$160
  • Alkermes, Inc.$125
  • plus $24 from 1 others

What the payments were for

  • Food & beverage$2,78396%
  • Education$1074%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,889 in reported general payments places this provider in the 90th percentile of 30 psychosomatic medicine providers in New York.

See all psychosomatic medicine providers in New York

Medicare billing

Part B allowed, 2024
$2,428
Medicare patients
18
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl22$1,903
Ziprasidone Hcl38$790
Bupropion XlBupropion Hcl50$560
Doxepin Hcl29$482
Mirtazapine16$473
Aripiprazole14$364
Quetiapine Fumarate ErQuetiapine Fumarate24$351
Trazodone Hcl66$238
Quetiapine Fumarate24$220
Amitriptyline Hcl14$216
Olanzapine11$197
Haloperidol23$187
Zolpidem Tartrate25$144
Citalopram HbrCitalopram Hydrobromide13$91
Paroxetine Hcl13$88

Paid to pharmacies, not to this prescriber.

Other psychosomatic medicine in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →